Citation: | HU Lixin. RP-HPLC determination of two stereoisomers in latanoprost eye drop[J]. Journal of China Pharmaceutical University, 2017, 48(5): 596-600. DOI: 10.11665/j.issn.1000-5048.20170515 |
[1] |
Allaire C,Dietrich A,Allemier H,et al.Latanoprost 0.005% test formulation is as effective as Xalatan in patients with ocular hypertension and primary open-angle glaucoma[J]. Eur J Ophthalmol,2012,22(1):19-25.
|
[2] |
Zanoni G,D′ Alfonso A,Porta A,et al.The meyere-schuster rearrangement:a new synthetic strategy leading to prostaglandins and their drug analogs,bimatoprost and latanoprost[J].Tetrahedron,2010,66(38):7472-7477.
|
[3] |
Martynow JG, Jozwik J, Szelejewski W, et al. A new synthetic approach to high-purity(15R)-latanoprost[J].Eur J Org Chem,2007,2007(4):689-695.
|
[4] |
Xiu ZM,Wang LC,Huang MY,et al.A novel method for the synthesis of latanoprost[J]. Chin J Org Chem(有机化学),2014,34:1786-1791.
|
[5] |
Widomski P,Baran P,Golebiewski P,et al.Validated liquid chromatographic method for analysis of the isomers of latanoprost[J].Acta Chromatographica,2008,20(2):157-164.
|
[6] |
Pan DJ,Chen QF,Zhang JD,et al.Determination of the related substances in latanoprost eye drops by NP-HPLC[J].Chin J Pharm(中国医药工业杂志),2013,44(9):932-934.
|
[7] |
Chinese Pharmacopoeia Commision.Chinese Pharmacopoeia:part 4(中华人民共和国药典:四部)[S].Beijing:China Medical Science Press.2015:374.
|
[8] |
Zhang L.Qualitative and quantitative analysis for determination of related substances in piracetam raw materials and its injection[J]. Chin J Pharm Anal(药物分析),2014,34(6):1062-1066.
|